Functional evaluation of cytochrome P450 2D6 with Gly42Arg substitution expressed in Saccharomyces cerevisiae
Authors:
- Chie TakemiCTChie Takemi
- Shigeo YamamotoSYShigeo Yamamoto
- Keietsu TamagakeKTKeietsu Tamagake
- Susumu ImaokaSISusumu Imaoka
- Yoshihiko FunaeYFYoshihiko Funae
- Hiroyuki KataokaHiroyuki Kataoka
- Sumio ShinodaSSSumio Shinoda
- Shizuo NarimatsuSNShizuo Narimatsu
- 1 November 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 11 (8) , 709-718
Abstract
A single amino acid-substituted mutant protein, CYP2D6 (G42R) was expressed in Saccharomyces cerevisiae and its enzymatic properties were compared with those of other single (P34S, R296C and S486T) and double amino acid-substituted mutant proteins (P34S/S486T and R296C/S486T) expressed in yeast cells, all of which were known to occur in the CYP2D6 gene as single nucleotide polymorphisms. The protein levels of G42R, P34S and P34S/S486T in microsomal fractions and their oxidation capacities towards debrisoquine as a prototypic substrate and bunitrolol as a chiral substrate were different from those of wild-type CYP2D6, while the R296C, S486T and R296C/S486T behaved similarly to the wild-type in these indices. The CYP contents both in yeast microsomal and in whole cell fractions indicated that some part of G42R protein was localized in the endoplasmic reticulum membrane fraction, whereas most of G42R protein was in some subcellular fractions other than endoplasmic reticulum. In kinetic analysis, the G42R substitution increased apparent K m and decreased V max for debrisoquine 4-hydroxylation, while it increased both K m and V max for bunitrolol 4-hydroxylation. The P34S substitution did not drastically change K m but decreased V max for debrisoquine 4-hydroxylation, whereas K m was increased and V max unchanged or decreased for bunitrolol 4-hydroxylation by P34S substitution. These results suggest that the G42R substitution causes a change in the CYP2D6 conformation, which may be different from the change produced by the P34S substitution.Keywords
This publication has 32 references indexed in Scilit:
- The Decreased in Vivo Clearance of CYP2D6 Substrates by CYP2D6*10 Might Be Caused Not Only by the Low-Expression but Also by Low Affinity of CYP2D6Archives of Biochemistry and Biophysics, 2000
- Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric EnzymeJournal of Biological Chemistry, 2000
- A Novel Approach to Predicting P450 Mediated Drug Metabolism. CYP2D6 Catalyzed N-Dealkylation Reactions and Qualitative Metabolite Predictions Using a Combined Protein and Pharmacophore Model for CYP2D6Journal of Medicinal Chemistry, 1999
- Dual Targeting Property of the N-terminal Signal Sequence of P4501A1Journal of Biological Chemistry, 1999
- Novel Approach To Predicting P450-Mediated Drug Metabolism: Development of a Combined Protein and Pharmacophore Model for CYP2D6Journal of Medicinal Chemistry, 1999
- Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102 : structural studies on specific CYP2D6substrate metabolismXenobiotica, 1997
- A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteineNaunyn-Schmiedeberg's Archives of Pharmacology, 1994
- Crystal structure and refinement of cytochrome P450terp at 2·3 Å resolutionJournal of Molecular Biology, 1994
- High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liverAnalytical Biochemistry, 1987
- Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresisBiochemistry, 1982